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proliferator
L.L. Hsiehl,*, H. Shinozuka2 & I.B. Weinstein'
'Comprehensive Cancer Center andDivision ofEnvironmental Sciences ofthe School ofPublic Health, Columbia University, New
York, New York 10032; and 2Department ofPathology, University ofPittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Summary Previous studies have demonstrated that BR-931, a hepatic peroxisome proliferator, can induce
liver tumours in mice and rats. Since alterations in gene expression may play a critical role in multistage
hepatocarcinogenesis, the present studies examined the expression of the c-myc, c-H-ras, epidermal growth
factor (EGF) receptor and ODC (ornithine decarboxylase) genes, as well as endogenous retrovirus-like
sequences, in F344 rat liver during the first 8 weeks of feeding a 0.16% Br931 diet and in liver tumours
induced by chronic feeding of this diet. Northern blot analysis of poly A+ liver RNA samples showed an
increase in the level of RNAs homologous to rat leukaemia virus (RaLV) but no significant change in the level
of 30S-retrovirus related RNAs in the liver RNA samples obtained from rats during the first 8 weeks of
feeding the diet containing BR931. An increase in the levels of c-myc, c-H-ras and ODC transcripts was also
seen in the liver RNA samples from the treated rats. Of particular interest was a decrease in the abundance of
EGF receptor transcripts in the liver RNA samples from rats fed the BR931 diet. Increased levels of RaLV,
c-myc, and ODC RNAs were also seen in the tumours induced by BR931, but this was not the case for 30S
and c-H-ras. The liver tumour samples also showed a decrease in EGF receptor RNA. These changes in
cellular levels of specific RNAs resemble, in several respect, those we previously described in rodent liver
during regeneration and tumour promotion, and also those seen in rodent hepatomas induced by other agents.
Therefore, they may reflect a common profile of gene expression relevant to liver proliferation and carcino-
genesis.
BR931, an ethanolamine derivative ofWy-14,633 [4-chloro-6-
(2,3-xylidino)-2-pyrimidinythio]acetic acid, has been shown to
possess both hypolipidemic and antiatherogenic properties, as
well as induction of hepatomegaly and hepatic peroxisome
proliferation (Sirtori et al., 1977; Reddy et al., 1987; Butter-
worth et al., 1987). Chronic administration of BR931 and
other peroxisome proliferators results in the induction of
hepatocellular carcinomas in rats and mice (Reddy et al.,
1980; Reddy & Rao, 1986; Butterworth et al., 1987; Rao &
Reddy, 1987). The precise mechanism oftheir carcinogenicity
is not well defined because classical genotoxicity tests have
been negative (Reddy & Lalwani, 1983; Butterworth et al.,
1987; Elliott & Elcombe, 1987) and tumour promotion
studies have shown variable results (Popp et al., 1987). Alter-
ations in DNA were recently demonstrated by sensitive 32p
postlabelling technique in liver samples obtained from rats
fed the peroxisome proliferator ciprofibrate (Randerath et al.,
1989).
There is accumulating evidence that altered expression of
specific cellular proto-oncogenes is associated with carcino-
genesis and tumour formation (Bishop, 1987; Weinberg,
1989). In previous studies from this laboratory, enhanced
expression of endogenous retrovirus-related sequences has
also been found in carcinogen-induced rat liver and colon
tumours (Hsieh et al., 1987; Guillem et al., 1988), and during
liver cell proliferation after partial hepatectomy (Hsiech et
al., 1988). We have also observed increased expression of
these endogenous retrovirus-like sequences in carcinogen- or
UV-treated rat fibroblast cell cultures (Lambert et al., 1983;
Ronai et al., 1988; Hsieh & Weinstein, 1990), although the
full significance of these changes with respect to the process
of neoplastic transformation is not understood. The present
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studies were designed, therefore, to examine the expression of
both cellular proto-oncogenes and endogenous retrovirus-like
sequences in F344 rat liver during the first 8 weeks of feeding
a diet containing BR931 and in liver tumours induced by
chronic feeding of this diet.
Materials and methods
Animal and tissue samples
Male Fischer 344 rats (Harlen Sprague Dawley, Inc, Indiana-
polis, IN), weighing 140-150 g at the beginning of the
experiments, were used. The basal diet was obtained from
Dyets, Inc., Bethlehem, PA. BR931 (LPB Instituto Farma-
ceutica S.P.A., Milan, Italy) and BR931 was incorporated in
the basal diet at a concentration of 0.16%. Water was supp-
lied ad libitum. On days 3, 7, 14, 28 and 56 after feeding of
the designated diets was started, rats were sacrificed by
cervical dislocation, and their livers were removed, quickly
frozen in liquid nitrogen, and stored at - 70'C. After long
term feeding of BR931, approximately 8-9 months, hepatic
tumours and normal-adjacent livers were quickly removed,
frozen in liquid nitrogen, and stored at - 70°C.
RNA isolation and Northern blot analysis
Frozen liver tissues were homogenised in guanidine mono-
thiocyanate, using a Polytron homogeniser (Brinkmann
Instruments, Westbury, NY), and total RNA was isolated by
the method of Chirgwin et al. (1979). The polyadenylated
RNA fraction was then isolated by passage of this RNA
through oligodeozy-thymidylate cellullose columns (Colla-
borative Research, Waltham, MA) (Aviv & Leder, 1972).
Five jig samples of polyadenylated RNA were subjected
to electrophoresis on 1% agarose gels that contained 6%
formaldehyde and were then transferred to Hybond-N hybri-
disation transfer membranes (Amersham Corporation, Arling-
ton Heights, IL). The membranes were then irradiated with
UV light for 2-5 min. Hybridisation to appropriate 32p_
!abelled probes (see below) and autoradiography were per-
Br. J. Cancer (1991), 64, 815-820 '." Macmillan Press Ltd., 1991816 L.L. HSIEH et al.
formed according to Wahl et al. (1979). After hybridisation
to one probe and autoradiography, some filters were washed
extensively and rehybridised to a second probe. A non-
polyadenylated RNA sample was included in each gel to
provide rRNA molecular size markers (5.0 and 2.0 kilo-
bases). In order to visualise the markers and the amount of
RNA present in each lane, the gels were stained with ethi-
dium bromide. The ethidium bromide staining indicated that
all lanes contained approximately equivalent amounts of
RNA. The relative abundance of specific transcripts in the
different lanes was determined by densitometric analysis of
the autoradiographs employing a Molecular Dynamics 300A
computing densitometer (Molecular Dynamics, Sunnyvale,
CA). 'Fold induction' in a specific RNA was calculated as
the ratio of the mean value (four or six animals/group) of
abundance of that RNA in rats fed the BR391 diets to the
corresponding value of the same RNA present in age-match-
ed rats fed the basal diets (Govindarajulu, 1988).
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Hybridisation probes
The following DNA fragments were used: 30S, 5.4 kilobase
Sacd fragment excised from a pUc8 recombinant (Young et
al., 1980; rat leukaemia virus (RaLV)), 8.2-kilobase Sacd
fragment excised from the vector AgtWES.AB (Gonda et al.,
1982); Ha-ras-specific insert, 460-base EcoRI fragment excis-
ed from the BS-9 clone (Ellis et al., 1980); c-myc, a 1.5-
kilobase PstI fragment excised from a pBR322 clone (Stanton
et al., 1983); epidermal growth factor (EGF) receptor, a
768-base EcoRI fragment excised from HER64.3 plasmid
(Ullrich et al., 1984); and ODC, a 2.4-kilobase EcoRI-
BamHI fragment excised from pmODC-l plasmid (Kahana
& Nathans, 1985). The purified fragments were 32P-labelled
by nick translation (Rigby et al., 1977).
Results
Expression ofendogenous retroviral sequences
Rat leukaemia virus (RaLV) Northern blot hybridisation
analysis was used to quantitate the expression levels of retro-
virus-related sequences in rat livers. Messenger RNA tran-
scripts, about 6.8 kilobases long, homologous to RaLV were
detected in all of the liver samples from rats fed either the
basal or BR931 diet. The results obtained with 12 representa-
tive samples are known in Figure la. There was some
interindividual variation in the level of expression of RaLV
transcripts between animals in the same treatment group.
The BR931 diet led to a slight increase (about 1.7-fold) in the
level of RaLV RNA (Table I), when compared to age-
matched rats fed the basal diet. The level of these transcripts
was found to be increased as early as day 3, which decreased
to almost the control level at day 14 after the start of the
BR931 diet.
Messenger RNA transcripts homologous to RaLV were
also detected in the liver tumour samples and in all of the
'normal' tumour-adjacent liver samples (Figure 2). The rela-
tive abundance of these transcripts was increased (about
2-fold) in liver tumours induced by BR931, when compared
to the results obtained with liver RNA samples obtained
from age-matched rats fed the basal diets (Table II). The
relative abundance of these transcripts was, however, not
significantly different between the 'normal' tumour-adjacent
and liver tumour samples (Figure 2 and Table II).
30S In addition to RaLV sequences, the rat genome also
contains another family of retrovirus-related sequences desig-
nated '30S'. Messenger RNA transcripts, about 8.4 kilobases
long, homologous to a 30S probe (similar to those shown in
Figure 2) were detected in all of the liver samples from rats
fed either the basal or BR931 diet. No significant interindivi-
dual variation in expression of 30S transcripts was observed.
Nor did the feeding of the BR931 diet influence the level of
this RNA species (Table I).
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Figure 1 Representative Northern blot analyses of the expres- sion of RaLV endogenous retrovirus-related sequences and the
c-H-ras gene (panel a); c-myc and ODC genes (panel b); and the
EGF receptor gene (panel c). 32P-labelled probes corresponding
to the indicated sequences were hybridised to polyadenylated RNA samples isolated from rats fed control or BR931 diets.
Lanes 1-6, rats fed control diets; lanes 7-12, rats fed BR931
diets. In panel a the samples were obtained on day 3, and in
panels b and c on day 56, following the onset of the control or
BR931 diets. For additional details see Materials and methods.
Messenger RNA transcripts homologous to 30S were also
detected in all of the liver tumour and the parallel control liver and 'normal' tumour-adjacent liver samples (Figure 2). The levels ofexpression of30S were not significantly different between the liver tumour, control liver and 'normal' tumour-
adjacent samples (Table II).
Expression ofcellularproto-oncogenes
c-myc Messenger RNA transcripts, about 2.5 kilobases long, homologous to c-myc were detected in all of the liver
samples from rats fed either the basal or BR931 diet. The
results obtained with 12 representative samples are shown in
Figure lb. There was some interindividual variation in the
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Table I Summary of abundance of various RNAs in rats fed BR931 diets
Fold induction
3 days I week 2 weeks 4 weeks 8 weeks
Retrovirus-like sequences
RaLV 1.54±0.70a 1.69±0.40 1.18±0.45 1.16±0.30 1.12±0.24
30S 1.10±0.49 0.97±0.28 0.95±0.32 0.91±0.24 0.98±0.17
Proto-oncogenes
c-myc 2.92±2.27 3.20± 1.89 4.21±2.41 6.10±1.86 8.07± 3.32
c-H-ras 1.97±0.50 1.57±0.39 1.54±0.51 0.94±0.18 0.95±0.35
EGF receptor 0.45±0.17 0.40±0.09 0.30±0.09 0.45±0.19 0.59±0.16
ODC 1.71±0.19 1.48±0.15 1.69±0.38 1.90±0.66 1.86±0.22
The data are expressed asfold induction ofthe abundance ofthe respective transcripts
by densitometry of the Northern blots, in Fischer 344 rats fed the BR931 diets when
compared to age-matched rats fed the basal diets. For details see Materials and methods.
aRatio ofmeans±s.d.
level of expression of the c-myc transcript between animals in
the same treatment group. The BR931 diet led to a marked
increase (about 8-fold) in the level of c-myc, when compared
to age-matched rats fed the basal diet. The level of these
transcripts was found to be increased as early as day 3, and
reached a maximum at day 56 (Table I). An additional
finding was that the level of c-myc in normal liver decreased
with age in the rats fed the basal diet; thus, the level ofc-myc
at day 3 was about 2.3-fold higher than the level at day 56
(data not shown here).
The relative abundance of c-myc mRNA transcripts was
increased about 2-fold in liver tumours induced by BR931,
when compared to that found in liver RNA samples from
age-matched rats fed the basal died (Figure 2 and Table II).
The relative abundance of these transcripts was, however, not
sigificantly different between the liver tumour s
the samples from 'normal' tumour-adjacent sar
II).
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Figure 2 Northern blot anaylsis of the expression o1
30S endogenous retrovirus-like sequences; c-myc, c-]
receptor and ODC genes. 32P-labelled probes corre,
the indicated sequences were hybridised to polyaden3
samples isolated from control livers; as well as 'norm
adjacent and liver tumour samples induced by the
Lanes 1-4, control livers from rats fed the basal diet
liver tumours from rats fed the BR931 diet; lanes 9-
tumour-adjacent liver samples from rats fed the BR9
the same number order as lanes 5-8. For additiona
Materials and methods.
TableII Summaryofabundanceofvarious RNAsinratlivertumours
induced by BR931
Fold induction
Tumour 'Normal'-adjacent
Retrovirus-like sequences
RaLV 1.98±0.58 1.32±0.54
30S 0.97±0.29 0.80±0.19
Proto-oncogenes
c-myc 2.12±1.22 2.53± 1.41
c-H-ras 0.87±0.24 1.02±0.18
EGF receptor 0.33±0.18 0.38±0.20
ODC 1.66±0.36 1.62±0.15
The data are expressed as described in Table I.
;amples and c-H-ras Messenger RNA transcripts, about 1.4 kilobases
iples (Table long, homologus to c-H-ras were detected in all of the liver
samples from rats fed either the basal or BR931 diet. The
results obtained with 12 representative samples are shown in
Figure la. There was slight interindividual variation in the
level of expression of the c-H-ras transcript between animals
in the same treatment group. The BR931 diet led to a slight
increase (about 2-fold) in the level of c-H-ras mRNA, when
- 6.8 kb compared to age-matched rats fed the basal diet. The level of
these transcripts was increased as early as day 3, but decreas-
ed to almost the basal level at day 28 (Table I).
The levels of expression of c-H-ras were not significantly
different between liver tumours, the normal liver samples
-8.4 kb from age-matched controls and the 'normal' tumour-adjacent
samples (Figure 2 and Table II).
Epidermal growth factor (EGF) receptor EGF receptor-
-2.5 kb related transcripts that were 10.5, 7.5 and 5.8 kilobases in size were found in all of the liver RNA samples obtained
from rats fed either the basal or BR931 diet. The results
obtained with 12 representative samples are shown in Figure
Ic. There was some interindividual variation in the level of
- 1.4 kb expression of EGF receptor transcripts between animals in
the same treatment group. The BR931 diet caused a marked
decrease (about 3.5-fold) in the level of EGF receptor RNA,
-10.5 kb when compared to age-matched rats fed the basal diet. The
level of these transcripts was found to be decreased as early
-- 7.5 kb as day 3, and persisted throughout the experiment (Table I).
-- -5.8 kb Messenger RNA transcripts homologous to EGF receptor
were also detected in all of the liver tumour samples, the
-2.6kb 'normal' tumour-adjacent tissues and the age-matched con-
-2.4 kb trol samples (Figure 2). The relative abundance of these
transcripts was decreased about 3-fold in the liver tumours
induced by BR931, when compared to liver samples from the
f RaLV and age-matched rats fed the basal diet (Table II). The relative
H-ras, EGF abundance ofthese transcripts was, however, not significantly
sponding to different between the 'normal' tumour-adjacent and liver
ylated RNA tumour samples (Table II).
ial' tumour-
3lanes 5-8, Ornithine decarboxylase (ODC) ODC-related transcripts
12, 'normal' that were 2.6 and 2.4 kilobases in size were seen in all of the 131 diet with liver RNA samples obtained from rats fed either the basal or
1 details see BR931 diet. The results obtained with 12 representative sam-
ples are shown in Figure lb. There was slight interindividual
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variation in the level of expression of the ODC transcript
between animals in the same treatment group. The BR931
diet led to a slight increase (about 2-fold) in the level of ODC
RNA, when compared to age-matched rats fed the basal diet
(Table I). The level of these transcripts was found to be
increased as early as day 3, and persisted throughout the
experiment (Table I).
Messenger RNA transcripts homologous to ODC were
also detected in the liver tumour samples, the 'normal'
tumour-adjacent samples and the liver samples and the liver
samples from normal age-matched controls (Figure 2). The
relative abundance of these transcripts was increased-(about
1.7-fold) in the liver tumours induced by BR931, when com-
pared to the age-matched control samples (Table II). The
relative abundance of these transcripts was, however, not
significantly different between the 'normal' tumour-adjacent
and liver tumour samples (Table II).
Discussion
As mentioned in the Introduction, the mechanisms of hepato-
carcinogenesis by BR931, a member of the peroxisome proli-
ferator class of compound, are not well understood. The
ability of this compound to induce peroxisome proliferation
has been implicated in its carcinogenicity, presumably
through the production of oxygen radicals by these orga-
nelles (Reddy et al., 1980; Fahl et al., 1984). However, recent
studies indicate that the ability of these compounds to induce
sustained enhancement of liver cell proliferation, and not the
degree ofperoxisome proliferation, correlates with the degree
of tumour response (Marsman et al., 1988). Furthermore,
unlike hepatomas and their precursor lesions induced by
classic hepatocarcinogens,- those induced by hypolipidemic
peroxisome proliferators do not express the enzymes y-gluta-
myltranspeptidase and glutathione-S-transferase (Rao et al.,
1982; ibid, 1986). The present studies were, therefore, design-
ed -to investigate certain proliferation-related changes-in gene
expression in rats fed a BR931 containing diet for a 8 week
period and also in liver tumours eventually produced by this
diet.
Using Northern blot hybridisation analysis, we have found
that the expression of endogenous RaLV-related sequences
increased moderately during the first 7 days after the onset of
the BR931 diet. Increased levels of these RNAs were also
seen in liver tumours induced by the BR931 diet, when
compared to normal liver samples from age-matched rats fed
the basal diet. The levels of RNA transcripts homologous to
30S retrovirus-like sequences did not, however, change dur-
ing the first 8 weeks of feeding the BR931 diet. Nor, was
their increased expression of 30S-related RNAs in the liver
tumours. Previously studies from this laboratory have shown
that there is a marked increase in the expression of endo-
genous retroviral sequences related to both RaLV and 30Sin
diethylnitrosamine-induced rat hepatocellular adenomas and
carcinomas (Hsieh et al., 1987). We also found a dramatic
increase in the level of RaLV-related RNAs but not 30S
RNAs during liver regeneration induced by partial hepatec-
tomy (Hsieh et al., 1988). In cell culture studies we have also
demonstrated increased expression of RaLV- and 30S- relat-
ed sequences in log-phase rat fibroblast cells, when compared
to quiescent cells (Hsieh-& Weinstein, 1990). Thus increased
expression of these endogenous retrovirus-related genes is
often associated with cell proliferation, but the results
obtained with the 30S sequence suggest that other factors
also control its expression.
We observed a marked increases in the level of c-myc RNA during the first 8 weeks of feeding BR931. Higher levels of c-myc RNA were found in the control rat livers at
day 3 than at day 56, which is consistent with the association
of c-myc RNA with proliferation. After adjustment of -this
age factor, increased expression of c-myc (about 3-fold) was
found throughout the 8 week period of feeding BR931. In-
creased expression of c-myc RNA was also observed in the
liver tumour samples induced by BR931 diet, when compared
to age-matched rats fed the basal diet. Previous results
indicated that during rat liver regeneration there is a marked
increase in the level of c-myc RNA, which precedes the peak
of DNA synthesis (Hsieh et al., 1988), suggesting that c-myc
plays a role in regulating the entry of hepatocytes into the
cell cycle. We observed only a slight increase in the level of
c-H-ras RNA during the first 8 weeks of feeding the BR931
diet and no significant increase was seen in the liver tumour
samples. A slight increase in the level of c-H-ras RNA was
seen in regeneration rat liver (Hsieh et al., 1988). Thus,
increased expression of the c-H-ras gene does not appear to
play an important role in hepatocyte proliferation.
ODC is the first and rate-limiting enzyme in the biosyn-
thesis of polyamines in mammalian cells, and increases in
ODC enzyme activity are frequently associated with cell pro-
liferation (Pegg & McCann, 1982). In the present studies we
found increased levels of ODC RNA in rat livers during the
first 8 weeks of feeding the BR931 diet and also in the liver
tumour samples induced by this diet. These results provide
further evidence that this drug induces the expression of
markers associated with cell proliferation.
We observed about a 3-fold decrease in the abundance of
EGF receptor RNA transcripts in rat livers during the first 8
weeks of feeding the BR931 diet, and a similar decrease was
seen in the liver tumours induced by this diet. Previous
studies showed a marked suppression in EGF receptor bind-
ing in liver samples within 3 days after rats were fed the same
BR931 diet (Gupta et al., 1988), and other-investigators
(Bartles et al., 1990) have described a decrease in EGF
receptor protein and certain other plasma membrane proteins
in rat liver after the administration of peroxisome prolifer-
ators. These investigators did not, however, examine EGF
receptor mRNA levels. It has also been reported that partial
hepatectomy and phenobarbital treatment caused a decrease
in EGF receptor binding (Earp & O'Keefe, 1981; Hwang et
al., 1986; Eckl et al., 1988), and in the level of EGF receptor
mRNA (Hsieh et al., 1988). Rat liver tumours induced by
diethylnitrosamine also display a decrease in EGF receptor
binding (Carr et al., 1986) and EGF receptor mRNA (Hsieh
et al., 1987). A recent study indicates that the feeding of a
methy-deficient diet also leads to a decrease in the level of
EGF receptor mRNA in the livers of mice, within 7 days of
the onset of this diet (Hsieh et al., 1989). Taken together
these findings provide strong evidence that alterations in the
function of EGF may play an important role in liver cell
proliferation and hepatocarcinogenesis, although the underly-
ing mechanisms are not known at the present time.
In summary, the present studies indicate that the feeding
of drug BR931, which induces a peroxisome proliferation in
rodent livers and is a hepatocarcinogen, induces increased in
the expression of several genes related to cell proliferation,
including: RaLV-related sequences, c-myc, c-H-ras, and
ODC; but decreased expression of the EGF receptor gene.
Furthermore, liver tumours induced by the long term feeding
of the BR931 diet showed similar changes in the expression
of these genes. It is of interest that the increased levels of
RNA for RaLV, 30S, c-myc, and ODC; and the decreased
levels of RNA for EGF receptor seen in the liver tumours
induced by BR931 were also seen in the 'normal' tumour-
adjacent liver samples obtained from the same animals
(Tables I and II). This suggests that the compound BR931
produces long term alterations in gene expression related to
cell proliferation throughout the liver of rats receiving this
compound. Further studies are required to determine wheth-
er the altered levels of specific mRNAs found in the present
study reflect changes at the level of transcription or RNA
stabilisation, and whether these changes are due to a primary
effect of the drug BR931 or are secondary to the induction of
peroxisome proliferation. Since these changes in gene expres-
sion occur relatively early (within 3 days) after onset of the
feeding of this drug they may provide a useful marker for the
mechanisms by which this and related drugs eventually
induce liver -tumours in rodents. Our findings on altered gene
expression may also be relevant to the mechanisms of action
of the peroxisome proliferator class ofcompounds, in view ofALTERED GENE EXPRESSION IN BR931 HEPATOCARCINOGENESIS 819
the recent cloning of a peroxisome proliferator-activated
receptor which is a member of the steroid hormone receptor
superfamily. Presumably this protein functions as a transcrip-
tion factor that is specifically activated by peroxisome pro-
liferators and may, therefore, mediate the numerous effects of
this class of agents (Isseman & Green, 1990).
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